55
Participants
Start Date
May 6, 2024
Primary Completion Date
February 28, 2027
Study Completion Date
February 28, 2027
Proton radiotherapy
Patients who received R0 resection will receive 45GyE per 18 fractions proton irradiation. Patients who received R1 resection will receive 50GyE per 20 fractions proton irradiation. Patients with thymus cancer should receive combined platinum based chemotherapy (including etoposide combined with cisplatin / carboplatin / loplatin / nedaplatin, paclitaxel combined with cisplatin / carboplatin / loplatin / nedaplatin, Docetaxel combined with cisplatin / carboplatin / loplatin / nedaplatin) for at least 4 cycles.
combined platinum based chemotherapy
combined platinum based chemotherapy
RECRUITING
Shanghai Proton and Heavy Ion Center, Shanghai
Lead Sponsor
Jian Chen
OTHER